242
Participants
Start Date
April 12, 2018
Primary Completion Date
January 24, 2019
Study Completion Date
June 19, 2019
F-627
Day 3 of each cycle, i.e., 48 ± 4 h after starting chemotherapy
GRAN®
Since day 3 of each cycle, i.e., 48 ± 4 h after starting chemotherapy, continuous treatment for ≤ 2 weeks or until ANC recovers to 5.0 × 10\^9/L from nadir (investigators may refer to ANC test results from the Department of Laboratory Medicine of each study sites to decide when to discontinue GRAN®)
Fudan University Shanghai Cancer Center, Shanghai
Lead Sponsor
EVIVE Biotechnology
INDUSTRY